Industry News

Biotech

• CRISPR corrects DMD in mice for a year in Sarepta-supported study 2019/02/15
  A Duke lab at the center of a research pact with Sarepta is reporting promising results from a trial of CRISPR gene editing in mouse models of DMD. But the treatment has produced some off-target effec …
• TCR2 IPO hits midpoint, setting stage for trials of CAR-T rivals 2019/02/15
  TCR2 Therapeutics has priced its IPO at the midpoint of the target range. The offering stands to net TCR2 $67 million, setting it up to move cell therapies designed to better CAR-Ts through early-phas …
• Novel immunotherapy prevents cervical, lung cancer in mice 2019/02/15
  Researchers at the University of Louisville were testing a protein-based molecule they originally developed to boost the power of T cells in treating cancer when they made a surprising discovery: The …
• India’s Glenmark spins out NMEs into U.S. company 2019/02/15
  India’s Glenmark is rolling all of the new molecular entities (NMEs) in its pipeline into a separate U.S. company in an effort to speed the programs to market.
• FDA funding set to jump as Congress votes to avert shutdown 2019/02/15
  Congress has approved a budget deal to avert another government shutdown. The deal, which is due to be signed into law by President Trump, includes the biggest increase in FDA funding in several years …

Medical Devices

Error: Feed has an error or is not valid

Pharma

• With safety data, Bayer could challenge Erleada, Xtandi in prostate cancer: analyst 2019/02/15
  For years, Johnson & Johnson and the Pfizer-Astellas team have been the only players in their class of prostate-cancer fighters. But Bayer is waiting in the wings, and stellar new safety data coul …
• Egalet's 70% price increase shows the buy-and-hike strategy is alive and well 2019/02/15
  While Big Pharma's price increases these days are in the single digits—and still triggering Twitter outrage—some small companies aren't shying away from the old strategy of acquiring drugs a …
• Dr. Reddy's racks up more repeat violations at Bachupally formulations plant 2019/02/15
  Dr. Reddy’s, which has been struggling to bring a number of its key plants up to FDA standards, has been unable to learn from past mistakes, including at its formulations plant in Bachupally.
• FiercePharmaAsia—AstraZeneca’s China business; Pfizer Japan valsartan recall; Xofluza resistance 2019/02/15
  AstraZeneca's China business soared 25% in 2018 as cancer and respiratory drugs pulled through; Pfizer Japan is recalling valsartan combo drugs made using Mylan's tainted API; Japanese docto …
• Swayed by discounts, NICE finally backs Roche's Perjeta for postsurgery breast cancer 2019/02/15
  Looks like the third time was a charm for Roche’s Perjeta when it comes to stepped-up use in England. Thanks to new discounts, the cost-effectiveness watchdogs at NICE recommended the drug for use aft …

Vaccines

Error: Feed has an error or is not valid